Autolus Therapeutics plc, a biopharmaceutical company focused on next-generation programmed T cell therapies, announced that it will release its fourth quarter and full year 2024 financial results on ...
Good morning everybody, and welcome to IMI's 2024 Preliminary Results Presentation. I am joined here, as usual, by Dan Shook, our CFO. And the first thing to say is that 2024 was another strong year ...
Greetings and welcome to the PureTech Health 2024 Year End Financial Results Conference. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results